Alan — Valuation, Funding & Investors

Alan combines health insurance with care delivery and prevention in one digital platform, offering members Alan Clinic for round-the-clock clinician chats and video consults, a 24/7 AI medical assistant, and perks like discounted eyewear through Integrated Optics. It serves companies of all sizes, consumers such as retirees and the self-employed, and public bodies, with 25,000 companies and more than 650,000 members across Europe.

Jean-Charles Samuelian and Charles Gorintin founded Alan in France in 2016, becoming the first newly licensed health insurer in the country in three decades. The company has since expanded to Belgium, Spain and, with backing from Teachers' Venture Growth since 2022, Canada in 2024.

Listed funds carry late-stage private names. A fund's latest schedule of investments shows whether it holds Alan.

Often trade at a premium or discount to NAV.

Platforms match existing holders with buyers. Alan availability at any moment is set by the holders.

High minimums, transfer approval, company right-of-first-refusal.

Valuations, rounds and IPO status for every company in the directory — Alan included.

The routes section explains what is realistically available for a company at this stage.

No. Alan is a private company; its shares do not trade on a public exchange.

The last valuation is $5.5B (post-money, Jun 2026).

Lead investors for each round are in the funding timeline.

The closest health insurance / insurtech peers are on the competitors page.